- Home
- IHG vs ICLR Comparison
IHG vs ICLR Comparison
Compare IHG & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHG
- ICLR
- Stock Information
- Founded
- IHG 1777
- ICLR 1990
- Country
- IHG United Kingdom
- ICLR Ireland
- Employees
- IHG N/A
- ICLR N/A
- Industry
- IHG Hotels/Resorts
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- IHG Consumer Discretionary
- ICLR Health Care
- Exchange
- IHG Nasdaq
- ICLR Nasdaq
- Market Cap
- IHG 17.0B
- ICLR 14.3B
- IPO Year
- IHG N/A
- ICLR 1998
- Fundamental
- Price
- IHG $124.67
- ICLR $175.97
- Analyst Decision
- IHG Hold
- ICLR Buy
- Analyst Count
- IHG 3
- ICLR 15
- Target Price
- IHG N/A
- ICLR $210.64
- AVG Volume (30 Days)
- IHG 172.8K
- ICLR 981.9K
- Earning Date
- IHG 01-01-0001
- ICLR 10-22-2025
- Dividend Yield
- IHG 1.36%
- ICLR N/A
- EPS Growth
- IHG 21.99
- ICLR N/A
- EPS
- IHG 4.70
- ICLR 7.47
- Revenue
- IHG $5,120,000,000.00
- ICLR $8,102,602,000.00
- Revenue This Year
- IHG N/A
- ICLR N/A
- Revenue Next Year
- IHG $6.42
- ICLR $1.68
- P/E Ratio
- IHG $26.17
- ICLR $25.77
- Revenue Growth
- IHG 33.89
- ICLR N/A
- 52 Week Low
- IHG $94.78
- ICLR $125.10
- 52 Week High
- IHG $137.25
- ICLR $284.98
- Technical
- Relative Strength Index (RSI)
- IHG 56.94
- ICLR 43.09
- Support Level
- IHG $122.68
- ICLR $173.47
- Resistance Level
- IHG $126.11
- ICLR $198.30
- Average True Range (ATR)
- IHG 1.92
- ICLR 7.63
- MACD
- IHG 0.23
- ICLR -1.24
- Stochastic Oscillator
- IHG 80.50
- ICLR 8.27
About IHG Intercontinental Hotels Group
InterContinental Hotels Group operates 987,000 rooms across 19 brands addressing the midscale through luxury segments, as of Dec. 31, 2024. Holiday Inn and Holiday Inn Express constitute the largest brand, while Hotel Indigo, Even, Hualuxe, Kimpton, and Voco are newer lifestyle brands experiencing strong demand. The company launched a midscale brand, Avid, in 2017 and closed on a 51% stake in Regent Hotels in 2018. It acquired Six Senses in 2019 and launched another midscale brand, Garner, in 2023. Managed and franchised represent 99% of total rooms. As of Dec. 31, 2024, the Americas represented 53% of total rooms, with Greater China accounting for 20% and Europe, Asia, the Middle East, and Africa making up 27%.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.